Taiwan Semiconductor Manufacturing (TSM.US) stock fell more than 5% despite the fact that one of the world's biggest chip makers posted strong quarterly figures. Company earned 93 cents per U.S. share in the June quarter, up 18% year over year and in line with analyst estimates. The company's sales increased 28% to $13.29 billion in the second quarter. For the current quarter, the company expects revenue of $14.6 billion to $14.9 billion. The midpoint of $14.75 billion beat market expectations of $14.57 billion. Company’s sales in the year-earlier period were $12.4 billion.
However TSM short term outlook on the semiconductor market weighed on the sentiment. TSM believes the current supply squeeze will end in the near future. CEO CC Wei expects chip deliveries to carmakers in particular to pick up sharply in the current quarter and over the rest of the year. Company also considering opening a new fabrication plant in Japan.
Some investors consider this as spelling an end to the windfall that chipmakers have enjoyed in the first six months of 2021. As a result shares of other chipmakers also suffered losses: NXP Semiconductors (NXPI.US) stock lost nearly 4.0%, Nvidia (NVDA.US) shares fell 2.6% and Intel (INTC.US) dropped 1.15%
Taiwan Semiconductor Manufacturing (TSM.US) stock launched today’s session with a massive bearish price gap and is currently approaching the major support zone around $117.00 which is marked with the lower limit of the 1:1 structure, upward trendline and 200 SMA (red line). Should break lower occur, then downward move may accelerate towards next support at $107.77. Source: xStation5
Economic calendar: Macroeconomics and Fed Officials’ Speeches in Focus (31.10.2025)
Morning wrap (31.10.2025)
Amazon and Apple beat estimates. Will it lift Wall Street higher?
Apple slightly gains after earnings 🗽China sales misses estimates
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
